Ultrasound guided percutaneous treatment for splenic abscesses: The significance in treatment of critically ill patients

Table 1 Underlying pathology in patients with splenic abscess

Causes	n	%
Pancreatitis	8	22
Trauma	8	22
Stomach surgery	8	22
Deviscerated hydatid cyst	2	6
Nephrectomia	2	6
Liver cirrhosis	1	3
Spleen infarction	1	3
Unknown	6	16

Table 2 Bacterial isolates in patients with splenic abscess

Microorganism	n	Isolated from
		Pus	Blood	Pus andblood
Aerobes
Gram positive
Staphyloccocus aureus (SA)	6	3	1	2
Streptoccocus viridans (SV)	2	2	0	0
Enterococcus species	2	2	0	0
Gram negative
Klebsiella pneumoniae (KP)	6	4	1	1
Pseudomonas species	5	1	1	3
Escherichia coli (EC)	3	2	1	0
Gram positive + Gram negative SA + ECSV + KP	3 2	2 2	1 0	0 0
Anaerobes Bacteroides fragilis	1	1	0	0
Sterile culture	6	0	0	0
Total	36	19	5	6

Table 3 Type of treatment, hospital stay and number of surgeries prior to percutaneous treatment in patients with splenic abscess

Treatmentmethod	n	Hospitalstay (d)	Number of surgeries beforepercutaneous treatment
			One	Two	Three
PNA	11	9.4 ± 5.3	2	2	0
PNA/PCD	8	16.6 ± 8.7	4	0	0
PCD x 1	9	23.9 ± 17	5	1	1
PCD x 2	6	32.5 ± 10	1	2	1
PCD > 2	2	39.1 ± 7.1	0	1	1
Total	36	20.1 ± 14	12	6	3

PNA: Percutaneous needle aspiration; PCD: Percutaneous catheter drainage.

Table 4 Type of treatment and outcome in patients with splenic abscess

Treatmentmethod	n	Outcome of treatment
		Success	Death
PNA	11	10	1
PNA/PCD	8	7	1
PCD x 1	9	81	1
PCD x 2	6	5	1
PCD > 2	2	2	0
Total	36	32	4

PNA: Percutaneous needle aspiration; PCD: Percutaneous catheter drainage.

¹One patient underwent surgery after PCD.